Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Finasteride may increase hair growth and prevent baldness in men, but can cause sexual side effects.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

The research identified genes linked to male-pattern baldness and potential drug targets for treatment.

The study aims to find the most effective treatments for male pattern baldness.

Male-pattern baldness has a weak link to heart disease and some related health conditions.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Men with pattern baldness may have a higher risk of prostate issues.

Using platelet plasma growth factors in baldness surgery can increase the number of hair follicles.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Young men with male pattern baldness lose hair density over time without treatment.

Bald men are often viewed more negatively and as older than they really are.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Stopping minoxidil treatment resumes balding; continuous use needed for results.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Minoxidil keeps most hair growth from first year and twice-daily use is better with few side effects.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Injecting platelet-rich plasma (PRP) can increase hair growth rate and density in male pattern baldness.